Tamoxifen for the Prevention of Breast Cancer: Late Results of the Italian Randomized Tamoxifen Prevention Trial Among Women With HysterectomyUmberto Veronesi, Andrea DeCensi, B. Bonanni et al.|JNCI Journal of the National Cancer Institute|2007Cited by 242
“Classical” CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancerE Engelsman, Richard Sylvester, J.C.M. Klijn et al.|European Journal of Cancer and Clinical Oncology|1991Cited by 165
Outcome of special types of luminal breast cancerMarco Colleoni, Giulia Viale, Nicole Rotmensz et al.|Annals of Oncology|2011Cited by 123
Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapiesMarco Colleoni, Aron Goldhirsch, Nicole Rotmensz et al.|Annals of Oncology|2004Cited by 76
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapyEmilia Montagna, Marco Colleoni, Claudia Sangalli et al.|Annals of Oncology|2014Cited by 54